What eye ointment is recommended for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

Topical broad-spectrum antibiotics are recommended for bacterial conjunctivitis as they reduce symptom duration, improve clinical outcomes, and allow earlier return to school/work. 1

First-Line Treatment Options

  • Fluoroquinolones (ciprofloxacin 0.3%, ofloxacin 0.3%, levofloxacin 1.5%) are FDA-approved for bacterial conjunctivitis and have been shown to be effective as single-drug therapy 2
  • Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) have better coverage of gram-positive pathogens than earlier generation fluoroquinolones, though they are not FDA-approved specifically for bacterial conjunctivitis 2
  • Erythromycin ophthalmic ointment is effective and should be applied directly to the infected eye(s) up to six times daily, depending on the severity of the infection 3

Treatment Approach Based on Severity

  • For mild bacterial conjunctivitis: A 5-7 day course of broad-spectrum topical antibiotic accelerates clinical and microbiological remission and reduces transmissibility 1
  • For moderate to severe bacterial conjunctivitis: Obtain conjunctival cultures and Gram staining before initiating treatment, especially if gonococcal infection is suspected 1
  • For central or severe keratitis: A loading dose (every 5-15 minutes) followed by frequent applications (every hour) is recommended 2

Special Considerations

  • Gonococcal conjunctivitis requires systemic antibiotic therapy rather than topical treatment alone, with saline lavage to promote comfort and faster resolution 1
  • Chlamydial conjunctivitis requires systemic antibiotic therapy, especially in infants who may have infection at other sites 1
  • Ointments may be useful at bedtime in less severe cases and for adjunctive therapy, though they have limited corneal penetration 2
  • Cycloplegic agents may be used to decrease synechiae formation and reduce pain from anterior segment inflammation 2

Administration Guidelines

  • Apply approximately 1 cm of ointment directly to the infected eye(s) 3
  • For drops, frequency depends on severity - from twice daily for mild cases to hourly for severe cases 2, 1
  • Studies show bacteria are cleared in 7 days in self-limiting cases, but a 7-day course of antibiotics has been shown to eradicate bacteria within 5 days 2

Potential Pitfalls and Considerations

  • Bacterial resistance is a growing concern, particularly with MRSA infections 1
  • Poor adherence to frequent administration regimens can contribute to treatment failure 4
  • Individual risk factors for fluoroquinolone resistance include recent fluoroquinolone use, hospitalization, age, and recent ocular surgery 2
  • Return for follow-up if no improvement after 3-4 days of treatment 1
  • Indiscriminate use of topical antibiotics should be avoided as viral conjunctivitis will not respond to antibacterial agents 2

Most Common Pathogens

  • Haemophilus influenzae and Streptococcus pneumoniae are the most prevalent bacteria in pediatric bacterial conjunctivitis 5
  • Staphylococcus aureus, Staphylococcus epidermidis, and Moraxella species are also common pathogens 4

Patient Education

  • Educate patients about proper hygiene to break the chain of transmission 2
  • Infected individuals should wash hands frequently, use separate towels, and avoid close contact with others during the period of contagion (10-14 days from onset) 2

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Research

[Bacterial conjunctivitis: most prevalent pathogens and their antibiotic sensitivity].

Anales de pediatria (Barcelona, Spain : 2003), 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.